COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 2274: Articles 22731-22740  | Next

Characterizing COVID-19 Clinical Phenotypes and Associated Comorbidities and Complication Profiles
Lusczek, E. R., Ingraham, N. E., Karam, B., Proper, J., Siegel, L., Helgeson, E., Lotfi-Emran, S., Zolfaghari, E. J., Jones, E., Usher, M., Chipman, J., Dudley, R. A., Benson, B., Melton, G. B., Charles, A., Lupei, M. I., Tignanelli, C. J.
10.1101/2020.09.12.20193391 — Posted: 2020-09-14 Discussion: Onsite
Differences in innate Intracellular viral suppression competencies may explain variations in morbidity and mortality from SARS-CoV-2 infection.
Bello, S. O., Igumbor, E., Deeni, Y. Y., Ochu, C. L., Popoola, M. A.
10.1101/2020.09.13.20193524 — Posted: 2020-09-14
Lack of consideration of sex and gender in clinical trials for COVID-19
Brady, E., Nielsen, M. W., Andersen, J. P., Oertelt-Prigione, S.
10.1101/2020.09.13.20193680 — Posted: 2020-09-14
Inequality in access to health and care services during lockdown - Findings from the COVID-19 survey in five UK national longitudinal studies
Topriceanu, C.-C., Wong, A., Moon, J. C., Hughes, A., Bann, D., Chaturvedi, N., Patalay, P., Conti, G., Captur, G.
10.1101/2020.09.12.20191973 — Posted: 2020-09-14
Environment influences SARS-CoV-2 transmission in the absence of non-pharmaceutical interventions
Smith, T. P., Flaxman, S., Gallinat, A. S., Kinosian, S. P., Stemkovski, M., Unwin, H. J. T., Watson, O. J., Whittaker, C., Cattarino, L., Dorigatti, I., Tristem, M., Pearse, W. D.
10.1101/2020.09.12.20193250 — Posted: 2020-09-14 Discussion: Onsite
A snap shot of space and time dynamics of COVID-19 risk in Malawi. An application of spatial temporal model
Ngwira, A., Kumwenda, F., Munthali, E., Nkolokosa, D.
10.1101/2020.09.12.20192914 — Posted: 2020-09-14
Estimates of outbreak-specific SARS-CoV-2 epidemiological parameters from genomic data
Vaughan, T. G., Scire, J., Nadeau, S. A., Stadler, T.
10.1101/2020.09.12.20193284 — Posted: 2020-09-14
The Immune-Buffer COVID-19 Exit Strategy that Protects the Elderly
Rom-Kedar, V., Yaniv, O., Malka, R., Shapiro, E.
10.1101/2020.09.12.20193094 — Posted: 2020-09-14
Sero-surveillance (IgG) of SARS-CoV-2 among Asymptomatic General population of Paschim Medinipur District, West Bengal, India(Conducted during last week of July and 1st week of August 2020) - A Joint Venture of VRDL Lab (ICMR), Midnapore Medical College & Hospital & Department of Health and Family Welfare,Govt. of West Bengal, Paschim Medinipur
Satpati, P., Sarangi, S. S., Gantait, K., Endow, S., Mandal, N. C., Kundu, P., Bhunia, S., Sarangi, S.
10.1101/2020.09.12.20193219 — Posted: 2020-09-14 Discussion: Offsite
nanoDoc: RNA modification detection using Nanopore raw reads with Deep One-Class Classification
Ueda, H.
10.1101/2020.09.13.295089 — Posted: 2020-09-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).